Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2023-11-16 00:00:00 ET · period of report 2023-11-15 · accession 0001209191-23-055521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-16 | 2023-11-15 | DYN | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +93.7K | 178.1K | +111% | $0 |
| D | 2023-11-16 | 2023-11-15 | DYN | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +36.5K | 36.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-15 | A | A | 93,718 | $0.00 | 178,052 | D | — | — | (F1) Consists of shares of Common Stock issuable under 93,718 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on February 15, 2024. (F2) Includes 151,588 unvested RSUs. |
| 2 | Derivative | Stock Option (right to buy) | 2023-11-15 | A | A | 36,495 | $0.00 | 36,495 | D | $10.88 · — to 2033-11-14 | 36,495 Common Stock | (F3) This option was granted on November 15, 2023. The shares underlying the option are scheduled to vest over four years in equal monthly installments through November 15, 2027. |